jump to content  sitemap
Division of Gastroenterology, Hepatology and Nutrition : Department of Internal Medicine : College of Medicine : The Ohio State University
http://internalmedicine.osu.edu/cardiovascular//digestivediseases/8571.cfm

 
Chiara Braconi, MD
:: Directory ::
Faculty Members
Fellows
Staff
Research Staff
Chiara Braconi, MD
Nianyuan Huang
Lyudmyla Khrapenko, MS
Erica Swenson

Home > Directory > Research Staff > Chiara Braconi, MD

 

Chiara Braconi, MD
Post-doc Researcher

Room 514 Medical Research Facility
Tzagournis Building
420 W. 12th Avenue
Columbus, OH 43210
(614) 688-5954

Education

- MD, Medical School "Universita' Politecnica delle Marche", Ancona, Italy/2002
- Medical Oncologist, "Universita' Politecnica delle Marche", Ancona, Italy/2006

Professional Background

- Clinica di Oncologia Medica, Ospedali Riunti Ancona, Italy/Fellow in Medical Oncology, 2002-2006
- Queen Elizabeth Hospital, University of Birmingham, UK/Fellow in Medical Oncology, Jan - Sept 2005
- The Ohio State University, Post-doc Researcher, July 2007

Research Interests

- Oncology, Liver cancer

Recent Publications

     - Braconi, C; Bracci, R; Bearzi I; Banchi, ; Costagliola, A; Romina, C; Mandolesi, A; Ranaldi, R; Galizia, E; Cascinu, S; Rossi, G; Giustini, L; Latini, L; Nicola, V; Cellerino, R. KIT and PDGFRa mutations in 104 patients with Gastrointestinal Stromal Tumors (GISTs): a population-based study. Ann Oncol 2007. In press.

     - Berardi, R; Braconi, C;  Mantello, G; Scartozzi, M; Del Prete, S; Luppi, G; Martinelli, R; Fumagalli, M; Valeri, G; Bearzi, I; Marmovale, C; Grillo-Ruggieri, F; Cascinu, S. Anemia may influence the outcome of patients undergoing neo-adjuvant treatment of rectal cancer. Ann Oncol 2006. Nov;17(11):1661-1664.

     - Battelli, N; Massacesi, C; Braconi, C; Pilone, A; Manzione, L; Dinota, A; Corbelli, S; Scanni, A; Sturba, F; Giacomini, G; Morale, D; Giorgi, F; Tummarello, D; Cascinu, S. Paclitaxel and epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil for patients with stage IIIC breast cancer with ten or more involved axillary lymph nodes. Am J Clin Oncol 2006. Aug;29(4):380-384.

     - Scartozzi, M; Falcone, A; Pucci, F; Braconi, C; Pierantoni, C; Cavanna, L; Franciosi, V; Berardi, R; Beretta, G; Masi, G; Allegrini, G; Zaniboni, A; Labianca, R; Cascinu, S. Capecitabine and mitomycin C may be an effective treatment option for third-line chemotherapy in advanced colorectal cancer. Tumori 2006. Sep/Oct;92(5):384-388.

     - Berardi, R; Grilli, G; Romagnoli, E; Saladino, T; Freddari, F; Tamburrano, T; Galizia, E; Carbonari, G; Mariani, C; Braconi, C; Pierantoni, C; Battelli, N; Scartozzi, M; Cascinu, S. Paraneoplastic syndromes: a review. Clin Ter 2005. Nov/Dec;156(6):281-288.


Department of Internal Medicine http://www.internalmedicine.osu.edu

The Ohio State University | College of Medicine
Department of Internal Medicine | Division of Gastroenterology, Hepatology and Nutrition
N210 Doan Office Tower | 395 W. 12th Avenue | Columbus, OH 43210-1228
Ph: 614.293.6255 | Contact Us